The trials of interpreting clinical trials - A Bayesian perspective on colchicine following an acute coronary syndrome
{{output}}
Background: A 2022 meta-analysis concluded colchicine reduced the cardiac risk in secondary prevention. Nevertheless, a large, randomized clinical trial (RCT) continued to randomize patients to colchicine or placebo and in 2025 p... ...
